Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.
BACKGROUND
Drug prescribing to the elderly is extensive and often inappropriate. Furthermore, the number of drugs used is the most important risk factor for adverse drug reactions. Despite this, drug prescribing in the elderly in Sweden is high and increasing. In 2003 the Swedish National Board of Health and Welfare launched a set of indicators to evaluate the quality of drug therapy in the elderly. Use of this tool in combination with the Swedish computerized national register covering all persons receiving multi-dose drug dispensing (drugs dispensed in one dose unit bag for each dose occasion) would enable detection of inappropriate drug prescribing and could help reduce the risk of drug-related problems among the elderly.


OBJECTIVE
To assess the extent and quality of drug prescribing in younger and older elderly residents receiving multi-dose drug dispensing in ordinary nursing homes (NHs) and special care units for dementia (NHDs), and to evaluate the relationship between the quality of prescribing and the number of prescribers per resident, in a Swedish county.


METHODS
The computerized national pharmacy drug register provided the database and a cross-sectional design was used. Selected drug-specific quality indicators proposed by the Swedish National Board of Health and Welfare in 2003 were used to assess the quality of drug prescribing.


RESULTS
This study included 3705 residents. Their mean age was 85 years and 72% were women. The mean number of prescribed drugs was 10.3 per resident. The proportion of residents with prescriptions for psychotropic drugs was 80% in NHs and 85% in NHDs. The prevalence of each drug-specific quality indicator was as follows: long-acting benzodiazepines 16.4% (NHs) versus 11.7% (NHDs), anticholinergic drugs 20.7% versus 18.5%, drug duplication 14.6% versus 13.6%, three or more psychotropic drugs 25.6% versus 35.3%, class C interactions (drug combinations that may require dose adjustment) 41.9% versus 38.7% and class D interactions (drug combinations that should be avoided) 8.1% versus 5.6%. Younger elderly residents (age 65-79 years) had a lower quality of drug prescribing. An increasing number of prescribers per resident was associated with a lower quality of drug therapy.


CONCLUSIONS
We found a lower quality of drug prescribing, e.g. anticholinergic drugs prescribed to approximately 20% of residents of NHs and NHDs, and a higher rate of psychotropic drug use (>/=80%) compared with previous studies in NHs. Our results also demonstrated a negative correlation between quality of prescribing and number of prescribers per resident.
Olsson
Jonny
J
Department of Drug Safety, Medical Products Agency, Uppsala, Sweden.
Bergman
Asa
A
Carlsten
Anders
A
Oké
Thimothy
T
Bernsten
Cecilia
C
Schmidt
Ingrid K
IK
Fastbom
Johan
J
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D003704:Dementia / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D009735:Nursing Homes / Q000706:statistics & numerical data; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010820:Physicians / Q000592:standards / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians' / Q000592:standards*; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care; D012042:Registries; D013548:Sweden
D004364:Pharmaceutical Preparations
Pharm World Sci. 2002 Apr;24(2):46-54
12061133
Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50
12213688
Exp Gerontol. 2004 Nov-Dec;39(11-12):1731-8
15582289
Lakartidningen. 2001 Mar 21;98(12):1371-3
11320786
BMJ. 2008 Aug 28;337:a1227
18755769
J Psychiatr Pract. 2005 Jan;11(1):5-15
15650617
Drugs Aging. 2005;22(1):69-82
15663350
Arch Intern Med. 2003 Dec 8-22;163(22):2716-24
14662625
Drugs Aging. 1999 Feb;14(2):141-52
10084366
Drugs Aging. 1998 Feb;12(2):115-27
9509290
Ann Pharmacother. 2005 Mar;39(3):405-11
15671088
Int J Clin Pharmacol Ther Toxicol. 1989 Mar;27(3):102-16
2656543
Lakartidningen. 2001 Nov 21;98(47):5349-53
11763634
Neurol Sci. 2009 Apr;30(2):87-92
19229475
Int J Clin Pharmacol Ther Toxicol. 1989 Jan;27(1):13-26
2663734
Lakartidningen. 2004 Nov 11;101(46):3683-4, 3686-8
15586493
J Am Geriatr Soc. 1999 Jan;47(1):30-9
9920227
Age Ageing. 1994 May;23(3):255-9
8085514
J Am Geriatr Soc. 2001 Mar;49(3):277-83
11300238
Drugs Aging. 1991 Jul-Aug;1(4):289-302
1794021
Lakartidningen. 2004 Mar 11;101(11):994-6, 999
15055120
J Am Geriatr Soc. 1988 Mar;36(3):219-24
3339230
Int J Geriatr Psychiatry. 2001 Sep;16(9):900-6
11571771
J Am Geriatr Soc. 2004 Jun;52(6):861-6
15161447
J Am Geriatr Soc. 1995 May;43(5):513-9
7730533
Scand J Prim Health Care. 2008;26(2):86-91
18570006
Int J Geriatr Psychiatry. 2005 Aug;20(8):712-21
16035123
Drugs Aging. 1994 Jun;4(6):449-61
8075473
Ann Intern Med. 1995 Aug 1;123(3):195-204
7598302
J Am Geriatr Soc. 1988 Feb;36(2):142-9
3276767
JAMA. 2003 Apr 2;289(13):1652-8
12672733
Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):595-9
14558183
Eur J Clin Pharmacol. 2003 Sep;59(5-6):463-9
12920492
Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):65-72
11998554
N Engl J Med. 2009 Jan 15;360(3):225-35
19144938
Eur J Clin Pharmacol. 2001 Sep;57(6-7):523-8
11699620
Br J Clin Pharmacol. 1997 Jan;43(1):91-7
9056058
BMC Geriatr. 2009 May 21;9:18
19460135
Arch Intern Med. 1997 Jul 28;157(14):1531-6
9236554
CMAJ. 1997 Feb 1;156(3):385-91
9033421
Scand J Prim Health Care. 2007 Mar;25(1):9-14
17354153
Drugs Aging. 1999 Jul;15(1):15-28
10459729
J Am Geriatr Soc. 2002 Jun;50(6):995-1000
12110057
Drugs Aging. 1992 Jul-Aug;2(4):356-67
1504448
Am J Public Health. 1997 Mar;87(3):404-9
9096541